Folic acid and neural tube defects.
Wald
N J
NJ
Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK. n.j.wald@mds.qmw.ac.uk
D001682:Biological Availability; D004032:Diet; D004305:Dose-Response Relationship, Drug; D004739:England / Q000453:epidemiology; D005260:Female; D005433:Flour; D005492:Folic Acid / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D005494:Folic Acid Deficiency / Q000150:complications / Q000517:prevention & control*; D005527:Food, Fortified; D006710:Homocysteine / Q000097:blood; D006801:Humans; D017202:Myocardial Ischemia / Q000517:prevention & control; D009436:Neural Tube Defects / Q000453:epidemiology / Q000517:prevention & control*; D009753:Nutritive Value; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control*; D015995:Prevalence; D012307:Risk Factors; D014852:Wales / Q000453:epidemiology
D006710:Homocysteine; D005492:Folic Acid